Aktis Oncology, Inc. · NASDAQ:AKTS
Blue Owl Capital Holdings LP reported a 5.92% stake in Aktis Oncology, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 14, 2026
Blue Owl Capital Holdings LP reported a 5.92% stake in Aktis Oncology, Inc., 3,161,348 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G).
- Stake
- 5.92%
- Shares
- 3,161,348
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Owl Capital Holdings LP | 5.92% | 3,161,348 |